Clinical Trial Update: Post Approval NovaSure Essure Labeling Study

View source ↗

Summary

This post-approval labeling study update from Hologic assesses potential labeling changes for the NovaSure Endometrial Ablation System and the Essure Permanent …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia

Drugs mentioned

• Essure Permanent Birth Control System
• NovaSure Endometrial Ablation System

Snippet

Sponsor: Hologic, Inc. | Conditions: Menorrhagia | Status: UNKNOWN